For instance, human protein farnesyltransferase inhibitors (FTIs), which have been successful at suppressing tumour growth in pre-clinical studies [145], have been shown to induce dormancy in MCF-7 cells by upregulating protein expression levels of autophagy markers such as the Atg12 and Atg5 conjugate [146]. This evidence concerns the gene ATG5 and neoplasm.